IDEAYA Biosciences · 1 week ago
Vice President, Oncology Sales
South San Francisco, CA
Full-time
Hybrid
Director/Executive
$303K/yr - $374K/yr
15+ years expIDEAYA Biosciences is a precision medicine oncology company dedicated to developing transformative therapies for cancer. They are looking for a Vice President, Oncology Sales to lead the sales strategy for their first commercial product, focusing on launch readiness and commercialization in the oncology field.
BiotechnologyHealth CareOncologyTherapeutics
Responsibilities
Lead the development and implementation of the go-to-market and field sales strategy for the launch of the company's first oncology product in metastatic uveal melanoma [mUM]
Establish and refine key performance metrics, territory design, sales/CRM platforms, and incentive compensation structures to ensure effective execution and accountability
Partner cross-functionally to ensure sales strategies are informed by insights from marketing, insights/analytics, value & access, and medical affairs
Recruit, train, and develop an elite oncology sales force with a focus on clinical & business acumen, competitive selling, and customer & account management
Foster a culture of performance, collaboration, and integrity within the field organization
Develop and maintain strong relationships with key oncology centers, KOLs/HCPs, and community practices
Drive a customer- and patient-centric approach to engagement, ensuring alignment with compliance and corporate values
Champion the voice of the customer internally to shape strategy, messaging, and future product launches
Serve as a core member of the Commercialization Leadership and Launch Readiness Teams to prepare for darovasertib approvals and contribute to strategic and operational planning across the portfolio
Deliver tight financial management of FTE and operational budgets for the entire sales force function
Actively contribute to the annual brand planning, forecasting, and budgeting process
Keep abreast of market conditions, competitive activities, and technological trends through ongoing research and engagement at industry and medical conferences, literature reviews and other sources
Work in close collaboration with Marketing, Value & Access, Operations/Insights, Medical Affairs, Finance, & Legal to ensure the compliant achievement of business objectives
Travel - Position requires up to 75% travel
Qualification
Required
Undergraduate degree required, MBA and/or relevant post graduate qualifications preferred
Minimum of fifteen (15) years of multi-functional commercial pharmaceutical experience with at least 8 years in leadership roles overseeing field sales
Deep Oncology experience is required with rare oncology/disease experience a plus
Proven success in launch preparation and commercial oncology launches is critical
Inspirational leader with a successful track record of attracting, developing and retaining talent and building high performing teams
Strategic thinker with skillset to leverage multiple analytic approaches to deliver outstanding execution and results
Entrepreneurial mindset with the flexibility and resilience to thrive in a fast-paced, evolving biotech environment
Strong understanding of oncology market dynamics, innovative selling models, and the evolving regulatory/compliance environment
Possess strong executive presence, excellent communication and cross-functional collaboration skills
Preferred
MBA and/or relevant post graduate qualifications
Benefits
Medical/dental/vision coverage (100% company paid for employees and 90% company paid for dependents)
401k
ESPP
Wellness programs
Company
IDEAYA Biosciences
IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.
51-200 employees
Funding
Current Stage
Public CompanyTotal Funding
$694.1MKey Investors
5AM Ventures
2024-07-09Post Ipo Equity· $263M
2023-10-24Post Ipo Equity· $125M
2022-09-14Post Ipo Equity· $80M
Leadership Team
Yujiro S. Hata
CEO
Paul A. Stone
Chief Financial Officer & General Counsel
Recent News
2025-12-16
Company data provided by crunchbase